Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

Jun Yin^#¹, Jingnan Yuan^#^{2

3

4}, Yunjin Li^{2

4}, Yong Fang¹, Ruoxi Wang², Heng Jiao¹, Han Tang¹, Shaoyuan Zhang¹, Siyun Lin¹, Feng Su¹, Jianmin Gu¹, Tian Jiang¹, Dong Lin¹, Zhiliang Huang^{1

5}, Chaoxiang Du^{1

5}, Kui Wu^{6

7

8}, Lijie Tan^{9

10}, Qing Zhou^#^{11

12

13}

Affiliations

¹ Department of Thoracic Surgery, Cancer Center, Zhongshan Hospital of Fudan University, Shanghai, China.
² HIM-BGI Joint Lab, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, BGI-Hangzhou, Hangzhou, China.
³ Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI-Shenzhen, Shenzhen, China.
⁴ Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
⁵ Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
⁶ HIM-BGI Joint Lab, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, BGI-Hangzhou, Hangzhou, China. wukui@genomics.cn.
⁷ Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI-Shenzhen, Shenzhen, China. wukui@genomics.cn.
⁸ Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. wukui@genomics.cn.
⁹ Department of Thoracic Surgery, Cancer Center, Zhongshan Hospital of Fudan University, Shanghai, China. tan.lijie@zs-hospital.sh.cn.
¹⁰ Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China. tan.lijie@zs-hospital.sh.cn.
¹¹ HIM-BGI Joint Lab, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, BGI-Hangzhou, Hangzhou, China. zhouqing2@genomics.cn.
¹² Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI-Shenzhen, Shenzhen, China. zhouqing2@genomics.cn.
¹³ Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. zhouqing2@genomics.cn.

^# Contributed equally.

PMID: 37507607
PMCID: PMC10504064
DOI: 10.1038/s41591-023-02511-4

Published Erratum

Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

Jun Yin et al. Nat Med. 2023 Sep.

. 2023 Sep;29(9):2376.

doi: 10.1038/s41591-023-02511-4.

Authors

Affiliations

¹ Department of Thoracic Surgery, Cancer Center, Zhongshan Hospital of Fudan University, Shanghai, China.
² HIM-BGI Joint Lab, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, BGI-Hangzhou, Hangzhou, China.
³ Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI-Shenzhen, Shenzhen, China.
⁴ Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
⁵ Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
⁶ HIM-BGI Joint Lab, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, BGI-Hangzhou, Hangzhou, China. wukui@genomics.cn.
⁷ Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI-Shenzhen, Shenzhen, China. wukui@genomics.cn.
⁸ Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. wukui@genomics.cn.
⁹ Department of Thoracic Surgery, Cancer Center, Zhongshan Hospital of Fudan University, Shanghai, China. tan.lijie@zs-hospital.sh.cn.
¹⁰ Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China. tan.lijie@zs-hospital.sh.cn.
¹¹ HIM-BGI Joint Lab, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, BGI-Hangzhou, Hangzhou, China. zhouqing2@genomics.cn.
¹² Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI-Shenzhen, Shenzhen, China. zhouqing2@genomics.cn.
¹³ Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. zhouqing2@genomics.cn.

^# Contributed equally.

PMID: 37507607
PMCID: PMC10504064
DOI: 10.1038/s41591-023-02511-4

No abstract available

PubMed Disclaimer

Erratum for

Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial.
Yin J, Yuan J, Li Y, Fang Y, Wang R, Jiao H, Tang H, Zhang S, Lin S, Su F, Gu J, Jiang T, Lin D, Huang Z, Du C, Wu K, Tan L, Zhou Q. Yin J, et al. Nat Med. 2023 Aug;29(8):2068-2078. doi: 10.1038/s41591-023-02469-3. Epub 2023 Jul 24. Nat Med. 2023. PMID: 37488287 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

Affiliations

Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources